Clinical presentation and diagnosis of Gestational Trophoblastic Disease

Best Pract Res Clin Obstet Gynaecol. 2021 Jul:74:42-52. doi: 10.1016/j.bpobgyn.2020.12.001. Epub 2020 Dec 21.

Abstract

Gestational trophoblastic disease (GTD) is a heterogeneous group of pregnancy-related disorders characterized by abnormal proliferation of trophoblastic tissue. It encompasses the premalignant partial and complete hydatidiform mole but also the malignant invasive mole, choriocarcinoma, placental-site trophoblastic tumor, and epithelioid trophoblastic tumor. The clinical presentation changed to earlier detection after the introduction of first trimester ultrasounds. Patients are often asymptomatic, but vaginal bleeding continues to be the most common presenting symptom. Other symptoms can develop in the case of metastatic disease. Ultrasound, serum human chorionic gonadotrophin, and sometimes additional imaging such as CT, MRI, or PET can confirm the diagnosis and stage of disease. Familiarity with the pathogenesis, classification, imaging features, and treatment of GTD facilitates diagnosis and appropriate management.

Keywords: Diagnosis; Gestational trophoblastic disease; Imaging; Symptoms.

Publication types

  • Review

MeSH terms

  • Choriocarcinoma*
  • Female
  • Gestational Trophoblastic Disease* / diagnosis
  • Gestational Trophoblastic Disease* / therapy
  • Humans
  • Hydatidiform Mole* / diagnostic imaging
  • Placenta
  • Pregnancy
  • Uterine Neoplasms* / diagnostic imaging
  • Uterine Neoplasms* / therapy